[ Inside the business ]

ITRI stock analysis

ITRI · Itron, Inc.

Instruments for meas and testing of electricity and elec signals. Growing 3%. Keeps 14¢ of every dollar.

Watch: a leadership change.

The future, in 7 questions

Priced in: 0.7× sales in 5 yrs. Evidence: sales +3% · 14¢ profit/$1.

01 What's priced in?0.7× sales in 5 yrs
Sales now$2.3B
Needed in 5 yrs$1.7B
Backlog$1.6B
02 Is the wave rising?No Radar technology matched

Not among the companies mentioning Radar's technologies most.

03 Will customers keep buying?Sales +3%, steady
No customer over 10%
Backlog $1.6B · 0.7× salesPrepaid $291MSales +3%, steady
04 Is it scarce?No
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Keeps 14¢ per $1, rising
'21'22'23'24'2514¢
Before running costs: 29% → 38%
06 Can it fund itself?Pays its own way
05 yrsself-funded
Shares +0.5%/yrDebt $1.6B
07 What could break it?1 to watch
  • Moves strongly with the S&P 500

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth speeding up.

Sales growth −3%, −7%, then +3% vs. a year ago. A leadership change was filed on Nov 20.

What could go wrong

Few warning signs.

It has moved 1.2× the market. In the 2008 crisis it fell 58% while the market fell 51%. Debt is heavy.

Speculative check

Not classified.

Not Self-funding because of: debt over 4× operating profit.

What they sell

82% Product.

Product 82% · Service 18%

Where each dollar goes

14¢ profit.

59¢ to make what it sells, 27¢ on research and overhead, 14¢ left over. Revenue $2.3B in the last 12 months.

Its market

0.6× the economy.

The government expects its industry, navigational, measuring, electromedical, and control instruments manufacturing, to grow 1.1% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Maturity.

It earns cash, still invests, and pays back more than it borrows.

Earnings quality

Clean.

Its numbers don't resemble those of past manipulators. Cash covers 141¢ of each $1 of profit.

Competitive advantage

2 of 10 years.

Returns beat its 8.0% cost of capital in 2 of the last 10 years. Gross margin went from 33% to 38%.

Future bets

10% on research.

$221M a year on R&D. $27M on equipment and buildings.

All figures from Itron, Inc.'s SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.